Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OTC | P00480 | 1/20 | 0.53 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | FNTA | P49354 | 2/20 | 0.42 |
| ▸ | FNTB | P49356 | 2/20 | 0.42 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.42 |
| ▸ | ARG2 | P78540 | 4/20 | 0.42 |
| ▸ | ARG1 | P05089 | 3/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19733064 | 1.00 | OTC (0.53) | OTCNOD1TDP1GSRFNTA | |
| SCHEMBL18643429 | 0.92 | OTC (0.54) | OTCNOD1TDP1GSRFNTA | |
| SCHEMBL9922798 | 0.92 | OTC (0.54) | OTCNOD1TDP1GSRFNTA | |
| SCHEMBL12801715 | 0.92 | OTC (0.54) | OTCNOD1TDP1GSRFNTA | |
| SCHEMBL41534 | 0.87 | NOD1 (0.49) | OTCNOD1TDP1GSRFNTA | |
| SCHEMBL18656205 | 0.87 | OTC (0.59) | OTCNOD1TDP1GSRARG2 | |
| SCHEMBL10005285 | 0.86 | OTC (0.58) | OTCNOD1TDP1GSRARG2 | |
| SCHEMBL365299 | 0.86 | OTC (0.58) | OTCNOD1TDP1GSRARG2 | |
| SCHEMBL29486962 | 0.86 | OTC (0.58) | OTCNOD1TDP1GSRARG2 | |
| SCHEMBL13611057 | 0.85 | NOD1 (0.56) | OTCNOD1TDP1GSRGRM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1753803-B1 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | FARMHISPANIA (ES) | 2009-04-08 | — | — | EP | claimed |
| EP-1753803-A2 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | Farmhispania S.A. (ES) | 2007-02-21 | — | — | EP | claimed |
| WO-2005121215-A2 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | FARMHISPANIA, S.A. (ES) | 2005-12-22 | — | — | WO | claimed |
| US-20050276783-A1 | Polypeptides with the capacity to entrap drugs and release them in a controlled way | FARMHISPANIA, S.A. (ES) | 2005-12-15 | — | — | US | claimed |
| EP-2102267-A2 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS | Farmhispania S.A. (ES) | 2009-09-23 | — | — | EP | disclosed |
| EP-1753803-B1 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | FARMHISPANIA (ES) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008071594-A2 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS | FARMHISPANIA S.A. (ES) | 2008-06-19 | — | — | WO | disclosed |
| US-20070134335-A1 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | FARMHISPANIA S.A. (ES) | 2007-06-14 | — | — | US | disclosed |
| EP-1753803-A2 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | Farmhispania S.A. (ES) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005121215-A2 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | FARMHISPANIA, S.A. (ES) | 2005-12-22 | — | — | WO | disclosed |
| US-20050276783-A1 | Polypeptides with the capacity to entrap drugs and release them in a controlled way | FARMHISPANIA, S.A. (ES) | 2005-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070134335-A1 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | DNPEP, LNPEP, PTMS | OTC 1392/4885NOD1 3803/4885TDP1 2519/4885 |
| US-20050276783-A1 | Polypeptides with the capacity to entrap drugs and release them in a controlled way | DNPEP, LNPEP, PTMS | OTC 1392/4885NOD1 3803/4885TDP1 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.